Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

April 30, 2002

Conditions
Hepatitis CHepatitis C, Chronic
Interventions
DRUG

thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a

DRUG

placebo + PEGinterferon alfa-2a

Trial Locations (48)

Unknown

University of Alabama - Knollwood Physician's Group Bldg., Mobile

Mayo Clinic, Scottsdale

Gastroenterology Associates of East Bay Medical Group, Berkeley

Scripps Clinic, La Jolla

Cedars-Sinai Medical Center, Los Angeles

California Pacific Medical Center, San Francisco

Veterans Administration Medical Center GI Section (111B), San Francisco

Walter Reed Army Medical Center, Washington D.C.

Washington Hospital Center, Washington D.C.

University of Florida, Gainesville

Mayo Clinic, Jacksonville

University of Miami Center for Liver Diseases, Miami

Atlanta Gastroenterology Associates, Atlanta

Center for Digestive and Liver Health, Savannah

Idaho Gastroenterology Associates, Meridian

University of Chicago Hospital & Clinic, Chicago

Hepatitis C Treatment Centers, Inc., Louisville

Liver Research Center - University of Louisville, Louisville

Louisiana State University Healthcare Network, New Orleans

Johns Hopkins University, Baltimore

Chevy Chase Clinical Research, Chevy Chase

New England Medical Center, Boston

University of Massachusetts Memorial Medical Center, Worcester

William Beaumont Hospital, Royal Oak

Mississippi Gastrointestinal Associates, Jackson

VAMC, Kansas City

Saint Louis University Hospital, St Louis

North Shore University Hospital, Manhasset

Bronx VA Medical Center, New York

NY VAMC, New York

NYU Hospitals Center, New York

Carolinas Center for Liver Diseases, Charlotte

Duke University Medical Center, Durham

University of Cincinnati - College of Medicine, Cincinnati

Metro Health Medical Center, GI Division, Cleveland

Oregon Health Sciences University, Portland

University of Pennsylvania Hospital, Philadelphia

Roger Williams Medical Center, Providence

GI Center MidSouth, Memphis

University of Tennessee Gastroenterology, Memphis

Baylor University Medical Center, Dallas

University of Texas Southwestern Medical Center, Dallas

Baylor, VAMC, Houston

Metropolitan Research, Fairfax

McGuire Research Institute, Richmond

Wisconsin Center for Advanced Research, Milwaukee

Ponce School of Medicine, Ponce

Fundacion de Investigacion de Diego, Santurce

Sponsors
All Listed Sponsors
lead

SciClone Pharmaceuticals

INDUSTRY